KHKei Hosoda

Kei Hosoda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kei Hosoda has a total of 184 co-authors. Here are the top co-authors by number of shared publications:

  • Keishi Yamashita

    Division of Advanced Surgical Oncology, Department of Research and Development Center for New Medical Frontiers Kitasato University School of Medicine Sagamihara Kanagawa Japan

    33 shared publications
  • Masahiko Watanabe

    Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

    33 shared publications
  • Keishi Yamashita

    Division of Advanced Surgical Oncology Department of Research and Development Center for New Medical Frontiers Kitasato University School of Medicine Sagamihara Japan

    31 shared publications
  • Hiroaki Mieno

    Department of Surgery, Kitasato University School of Medicine, Sagamihara, Japan

    26 shared publications
  • Hiromitsu Moriya

    Department of Surgery, Kitasato University School of Medicine, Sagamihara, Japan

    25 shared publications
  • Marie Washio

    Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine

    21 shared publications

Latest Publications

  • Open Access

    Successful treatment with teduglutide in short bowel syndrome with intestinal failure secondary to small-bowel volvulus: a case report and literature review

    by Shingo Ito, Shota Akabane, Kei Hosoda, Shoichi Fujii

    Introduction and importance: Short bowel syndrome (SBS) is a major cause of intestinal failure (IF). Patients with SBS-associated IF (SBS-IF) often require long-term parenteral nutrition (PN) and suffer from complications that impair quality of life (QoL), including severe diarrhea, weight loss, sleep disturbances, and catheter-related bloodstream infections (CRBSIs). Teduglutide, a glucagon-like peptide-2 analog, enhances intestinal adaptation and reduces dependence on PN. However, evidence in patients with ultra-short residual bowel remains limited, particularly in Japan. We report a case of severe SBS-IF in which teduglutide enabled complete weaning from PN and substantial QoL improvement. Case presentation and clinical discussion: A 70-year-old man underwent an emergency, extensive small-bowel resection for small-bowel volvulus, leaving approximately 20 cm of small intestine with the colon in continuity. He developed SBS-IF requiring home PN and experienced watery diarrhea (more than 10 times per day), weight loss, sleep disturbance, and recurrent CRBSI. Four years after surgery, teduglutide was initiated. Within 4 months, stool consistency improved, bowel frequency decreased to 3–5 times per day, and absorption improved, allowing complete discontinuation of PN. Body weight stabilized, CRBSI resolved, and disease-specific QoL improved markedly. Conclusion: Even in ultra-short-bowel SBS-IF, teduglutide may achieve PN independence and clinically meaningful improvements in gastrointestinal symptoms, weight maintenance, and QoL.

  • Laparoscopic and Robotic Procedures Combined Surgery ( LARCS ): A Novel Approach to Trainee Participation in Robotic Gastrectomy

    by Motohiro Chuman, Hiroki Harada, Kei Hosoda, Masahiro Niihara, Keisuke Manaka, Kota Okuno, Shohei Fujita, Tadashi Higuchi, Koshi Kumagai, Takeshi Naitoh, et al.

    Background: Robotic gastrectomy (RG) for gastric cancer reduces morbidity and achieves long‐term outcomes comparable to laparoscopy. However, RG is typically a solo‐surgeon procedure performed by expert console surgeons, limiting trainees' operative experience. To address this issue, we developed Laparoscopic and Robotic procedures Combined Surgery (LARCS), in which the patient‐side surgeon (PSS) performs selected surgical maneuvers, including dissection, clipping, and stapling, using laparoscopic instruments under the supervision of the console surgeon. Methods: We retrospectively analyzed 96 patients who underwent robotic distal or subtotal gastrectomy at Kitasato University Hospital between January 2019 and December 2023. Patients were divided into a conventional RG group (CRG; n = 60) and a LARCS group ( n = 36). Propensity scores were estimated based on age, sex, body mass index, American Society of Anesthesiologists status, and clinical T and N categories. Cardinality matching within a 0.2‐standard‐deviation caliper of the logit of the propensity score yielded 23 matched pairs, with all absolute standardized mean differences for the matching covariates < 0.1. Perioperative outcomes and PSS participation were compared. Results: After matching, adequate balance was achieved for all matching covariates, with absolute standardized mean differences ranging from 0 to 0.062. Operative time was 406 min in the LARCS group and 373 min in the CRG group ( p = 0.110). Estimated blood loss tended to be greater with LARCS (51 vs. 6 mL, p = 0.070). Any postoperative complication occurred in 6 and 5 patients, respectively ( p = 1.000), and major complications occurred in 2 and 0 patients, respectively ( p = 0.500). Median PSS operative time was 108 min, corresponding to 26.6% of the total operative time in LARCS, versus 0 min in CRG ( p < 0.001). Conclusions: LARCS provided patient‐side trainees with supervised, instrument‐based first‐operator participation for approximately one‐quarter of the operative time, supporting its feasibility as a complementary approach to trainee participation during robotic gastrectomy. Further prospective studies incorporating objective competency‐based assessments are required to determine its educational effectiveness and safety.

  • Open Access

    Efficacy and safety of single-incision laparoscopic ileocecal resection using a dome port: A novel device: A case report

    by Shingo Ito, Tomohiro Yamamoto, Shota Akabane, Yuma Suno, Kei Hosoda, Shoichi Fujii

    This is the first case report of single-incision laparoscopic surgery using the Dome Port for colon cancer. Dome Port is designed to enhance the operability and safety of single-incision surgery. The key advantages are as follows. First, this device is made of transparent silicone, allowing the surgeon to directly visualize the insertion of surgical instruments. Second, the flexible silicone material minimizes interference between surgical instruments and the port. A 70-year-old female visited our hospital with occult blood test positive. She underwent a myoma resection approximately 20 years ago. A lower midline abdominal incision was present. Preoperative examination revealed the presence of advanced tumor in the cecum colon. Ileocecal resection was performed as the laparoscopic single-port technique using Dome Port. The procedure was performed safely, with an operation time of 138 min. The patient experienced minimal postoperative pain and resumed oral intake on postoperative day 2. The patient was discharged on postoperative day 6 without major complications. The Dome Port's transparent silicone construction allowed direct visualization of instrument insertion, enhancing procedural safety, while its flexible material minimized instrument interference and improved ergonomic manipulation. Compared to conventional single-incision ports, these features may reduce operative difficulty and the risk of instrument collisions, potentially contributing to smoother workflows and lower complication rates. The Dome Port was effective for single-incision laparoscopic ileocecal resection and may facilitate safer surgical procedures. It is expected to become one of the options for future reduced port surgery.

  • Isolated esophageal hiatal hernia of the colon: A case report and review of literature

    by Shinsuke Maeda, Shunichi Ito, Kei Hosoda

    Esophageal hiatal hernias, most of which are transhiatal migrations of the gastric cardia into the mediastinum, include a minor category called paraesophageal hernias. Herniation of organs other than the stomach belongs to this category. A 75‐year‐old man who developed esophageal hiatal hernia of an isolated transverse colon underwent elective laparoscopic surgery. Intraoperative findings revealed a preserved phrenoesophageal attachment on the patient's left dorsal side. Sac excision, sutured cruroplasty, and Toupet fundoplication were performed. The postoperative course was uneventful, and the patient's stooping‐induced dyspnea was relieved after surgery. Our literature review indicated that hiatal hernia of the isolated colon has the unique characteristic of causing secondary gastroduodenal outlet obstruction and shares a mutual nature with Type II hiatal hernia. Although rare, this uncommon type of hiatal hernia may be recognized as a distinct subtype of paraesophageal hernia.


  • Open Access

    The impact of histological subtype on postoperative recurrence pattern and timing in locally advanced esophagogastric junction cancer

    by Shinsuke Maeda, Masaho Ota, Shunichi Ito, Kei Hosoda

    Purpose: The differences in tumor behavior between adenocarcinoma (AC) and squamous cell carcinoma (SCC) of the esophagogastric junction (EGJ) have yet to be well investigated. The purpose of this study was to gain insights that can contribute to tailored treatments and follow-up strategies by analyzing the correlation between histological subtypes and oncological outcomes. Methods: A retrospective analysis was used to determine the characteristics of the histological subtypes of EGJ cancer by comparing the appearance of postoperative recurrence. A total of 102 consecutive patients with pathological stage IIA to IVA EGJ cancer, who underwent R0 surgery in our department from 2004 to 2020, were enrolled. The recurrence pattern, timing, survival, and potential prognostic factors were compared. Results: After a median follow-up time of 70.1 months, the AC group demonstrated comparable lymph node failure-free survival (P = 0.291) and significantly worse non-lymphogenous recurrence-free survival (P = 0.035) than did the SCC group. A significantly longer period from surgery to recurrence was also observed in the AC group (P = 0.029). Multivariate analysis indicated that histological subtype (P = 0.015, 95% CI 1.24–7.28) was significantly correlated with the incidence of non-lymphogenous recurrence. Conclusions: The pattern and timing of postoperative recurrence were significantly different between the histological subtypes of EGJ cancer. Compared with EGJ SCC, EGJ AC may have a greater tendency toward non-lymphogenous progression and a greater propensity for longer surgery-to-recurrence periods.

  • Open Access

    Prediction of Gastric Dilatation after Gastrectomy Using an Index from Abdominal X-Ray Radiography

    by Akiko Watanabe, Keishi Yamashita, Hiroki Harada, Motohiro Chuman, Marie Washio, Mikiko Sakuraya, Hideki Ushiku, Masahiro Niihara, Kei Hosoda, Naoki Hiki

    目的:胃切除後食物停滞による残胃拡張は誤嚥性肺炎や入院期間延長のリスクとなるが,残胃拡張を定義する明確な指標は存在しない.本研究では,胃切除後の腹部単純レントゲン(以下,X-pと略記)検査で得られる指標を用いて,胃拡張に対する治療介入と関連した臨床指数を同定することを目的とした.方法:2019年1月から8月の間に北里大学病院で施行された幽門側胃切除術を施行した95例中,術後に立位にて腹部単純X-p検査を行った77例を対象とした.観察しうる胃泡の最大幅,横隔膜下縁から胃泡の上縁までの距離(胃壁の厚さ),胃の縦径を計測し,椎体の中心から左横隔膜角までの距離で補正した.計測値と治療介入の有無との関係をROC曲線にて解析した.結果:77例のうち治療介入を必要とした症例は5例で,最も強く関連が示唆された臨床指数は椎体の中心から左横隔膜角までの距離と胃泡の最大幅の比であった(胃拡張インデックスと定義).この指標が,治療介入を予測する至適カットオフ値は51.0%と算出され,治療介入を予測する感度は100%,特異度は86%,AUCは0.94であった.結語:腹部単純X-p検査における胃拡張指数は,胃切除後の胃拡張に対する治療介入を予測する有用な指標となる可能性がある.


  • Open Access

    Short‐ and long‐term outcomes of robotic‐assisted laparoscopic surgery for rectal cancer: A single‐center retrospective cohort study

    by Takahiro Yamanashi, Hirohisa Miura, Toshimichi Tanaka, Akiko Watanabe, Takuya Goto, Keigo Yokoi, Ken Kojo, Masahiro Niihara, Kei Hosoda, Takashi Kaizu, et al.

    Introduction: Whether rectal cancer surgery by robotic‐assisted laparoscopic surgery provides beneficial advantages remains controversial. Although favorable outcomes in terms of the safety and technical feasibility of robotic‐assisted laparoscopic surgery have been demonstrated for rectal cancer, long‐term oncological outcomes for robotic‐assisted laparoscopic surgery have only been examined in a few studies. This retrospective study of subjects who underwent robotic‐assisted laparoscopic surgery evaluated short‐ and long‐term outcomes of consecutive rectal cancer patients.Methods: Between November 2016 and January 2020, we analyzed the records of 62 consecutive patients who underwent robotic‐assisted laparoscopic surgery for rectal adenocarcinoma without distant metastasis to evaluate short‐ and long‐term outcomes.Results: Tumors were located in the lower or mid‐rectum (88.7%) in most patients. The median operative time was 357 min. No patient received transfusions, and the median blood loss was 10.5 ml. Open laparotomy was not required in any patient. A Clavien–Dindo classification of all grades was observed in 12 patients (19.4%). Positive radial margin was not observed in any patient. Duration of median follow‐up was 40.5 mo, while 3‐y overall survival and 3‐y relapse‐free survival rates were 96.8% and 85.0%, respectively. The local recurrence rate was 3.4%.Conclusion: Favorable short‐ and long‐term outcomes demonstrated robotic‐assisted laparoscopic surgery was safe and technically feasible for rectal cancer.


  • Open Access

    Comparison of short‐term outcomes of robotic‐assisted and conventional laparoscopic surgery for rectal cancer: A propensity score‐matched analysis

    by Takahiro Yamanashi, Hirohisa Miura, Toshimichi Tanaka, Akiko Watanabe, Takuya Goto, Keigo Yokoi, Ken Kojo, Masahiro Niihara, Kei Hosoda, Takashi Kaizu, et al.

    Introduction: The advantages of robotic‐assisted laparoscopic surgery (RALS) for rectal cancer remain controversial. This study clarified and compared the short‐term outcomes of RALS for rectal cancer with those of conventional laparoscopic surgery (CLS).Methods: The records of 303 consecutive patients who underwent RALS or CLS for rectal adenocarcinoma between November 2016 and November 2021 were analyzed using propensity score‐matched analysis. After matching, 188 patients were enrolled in our study to compare short‐term outcomes, such as operative results, postoperative complications, and pathological findings, in each group.Results: After matching, baseline characteristics were comparable between groups. Although operative time in the RALS group was significantly longer than in the CLS group (p < 0.0001), the conversion rate to open laparotomy and the postoperative complication rate in the RALS group were significantly lower than in the CLS group (p = 0.0240 and p = 0.0109, respectively). Blood loss was comparable between groups. In the RALS group, postoperative hospital stay and days to soft diet were significantly shorter than those in the CLS group (p = 0.0464 and p < 0.0001, respectively). No postoperative mortality was observed in either group and significant differences were observed in resection margins and number of lymph nodes harvested.Conclusion: Robotic‐assisted laparoscopic surgery for rectal cancer was safe, technically feasible, and had acceptable short‐term outcomes. Further studies are required to validate long‐term oncological outcomes.


  • Open Access

    Prognostic Factors for Conversion Surgery in Patients with Unresectable Advanced Gastric Cancer

    by Hiroki Harada, Keishi Yamashita, Satoshi Tanabe, Kenji Ishido, Takuya Wada, Marie Washio, Mikiko Sakuraya, Hideki Ushiku, Masahiro Niihara, Kei Hosoda, et al.

    目的:切除不能進行胃癌に対する化学療法の進歩により,conversion手術症例に対する臨床経験は増加しているが,依然として予後不良な症例は多い.本研究の目的はconversion手術の長期予後を検討し,予後不良な因子を明らかにすることである.方法:2006年10月から2019年7月までの期間に,当院で切除不能進行胃癌に対してconversion手術を行った47例を対象とし,予後解析を行った.結果:(1)切除不能因子は肝転移8例,腹膜播種12例,領域外リンパ節転移22例,膵頭部浸潤5例であった.(2)切除不能進行胃癌におけるconversion手術のR0切除率は76.6%であった.1年,3年,5年全生存率は,93.6%,54.2%,34.6%であった.(3)多変量予後解析では,リンパ節転移陽性(HR 7.3,95%CI 2.46~24.7,P=0.0003)と深達度T4(HR 3.16,95%CI 1.04~9.96,P=0.0419)が独立した予後不良因子であった.(4)肝転移再発4例,腹膜播種再発7例,リンパ節転移再発3例における予後に有意な差は認めなかった(P=0.14).結語:切除不能進行胃癌におけるconversion手術症例ではリンパ節転移陽性と深達度T4が予後不良因子であった.

  • Pancreas-contactless gastrectomy for gastric cancer prevents postoperative inflammation

    by Hideki Ushiku, Mikiko Sakuraya, Marie Washio, Kei Hosoda, Masahiro Niihara, Hiroki Harada, Hirohisa Miura, Takeo Sato, Nobuyuki Nishizawa, Hiroshi Tajima, et al.

    Background Pancreas-related complications after laparoscopic gastrectomy (LG) for gastric cancer can be fatal. We developed a gastrectomy procedure with no pancreas contact to prevent such complications and herein report the surgical outcomes. Methods We retrospectively reviewed 182 consecutive patients with gastric cancer who underwent LG at Kitasato University Hospital from January 2017 to January 2020. These patients were divided into a pancreas-contact group (C group) and pancreas-contactless group (CL group) for comparison of postoperative complications, and inflammatory parameters such as body temperature (BT) and C-reactive protein (CRP). Results Postoperative complications of CDc grade ≧ IIIa were significantly fewer in the CL group than in the C group [0/76 (0%) vs. 6/106 (5.7%), P = 0.035]. The median drain amylase (drain-AMY) on postoperative day 1 (POD1) was significantly lower in the CL group than in the C group (641 vs. 1162 IU/L, P = 0.02), as was BT at POD1 (37.4 °C vs. 37.7 °C, P = 0.04), the patient group with a BT above 37.5 °C at POD3 [5/76 (6.5%) vs. 18/106 (17%), P = 0.037], and those showing a CRP above 20.0 mg/dL at POD3 [5/76 (6.5%) vs. 20/106 (19%), P = 0.018]. Conclusions Our technique to prevent pancreas contact during supra-pancreatic lymph node dissection during LG could minimize the inflammatory response and prevent further postoperative complications. Further large-scale, prospective studies are now required.